Preclinical and clinical studies indicate that psychostimulants, in addition to having abuse
potential, may elicit brain dysfunctions and/or neurotoxic effects. Central toxicity induced by …

Preclinical and clinical studies indicate that psychostimulants, in addition to having abuse
potential, may elicit brain dysfunctions and/or neurotoxic effects. Central toxicity induced by …

Introduction: Neurotoxicity caused by diverse psychostimulant drugs, for example,
methamphetamine, 3, 4-methylenedioxy-methamphetamine, cocaine or morphine is a cause …

Although a wealth of knowledge exists regarding the acute pharmacological effects of
recreational drugs on the CNS, much less is known about the long-term toxic effects of …

Psychostimulants abuse is a major public concern because is associated with serious health
complications, including devastating consequences on the central nervous system (CNS) …

Published since 1959, International Review of Neurobiology is a well-known series
appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists …

Over the course of the 20th century, it became increasingly clear that amphetamine-like
psychostimulants carried serious abuse liability that has resulted in sociological use patterns …

Studies have implicated methamphetamine exposure as a contributor to the development of
Parkinson's disease. There is a significant degree of striatal dopamine depletion produced …

Neurotoxicity is considered as a major cause of neurodegenerative disorders. Most drugs of
abuse have nonnegligible neurotoxic effects many of which are primarily mediated by …

Amphetamine-related drugs, such as 3, 4-methylenedioxymethamphetamine (MDMA) and
methamphetamine (METH) are popular recreational psychostimulants. Several preclinical …